Search research articles
Contact Us
Filters
Showing results (31-40 of 666) with videos related to
Page
of 67
Sort By:
Journal of Crohn'S & Colitis
|
November 29, 2019
Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice
Javier P Gisbert, María Chaparro
Gastroenterologia Y Hepatologia
|
December 5, 2020
How to prepare a research proposal in the health sciences?
Javier P Gisbert, María Chaparro
Journal of Crohn'S & Colitis
|
October 12, 2018
Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review
Javier P Gisbert, María Chaparro
Current Pharmaceutical Biotechnology
|
February 24, 2011
Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease
María Chaparro, Javier P Gisbert
Lancet (London, England)
|
October 23, 2016
Towards effective empirical treatment for Helicobacter pylori eradication
Francis Megraud, Javier P Gisbert
Gastroenterologia Y Hepatologia
|
October 19, 2017
Ustekinumab to treat Crohn's disease
Javier P Gisbert, María Chaparro
World Journal of Gastroenterology
|
September 24, 2008
Severe ulcerative colitis: at what point should we define resistance to steroids?
Maria Esteve, Javier P Gisbert
The American Journal of Gastroenterology
|
April 5, 2013
Response to Tung et al
María Chaparro, Javier P Gisbert
Therapeutic Advances in Chronic Disease
|
December 20, 2012
Usefulness of salicylate and thiopurine coprescription in steroid-dependent ulcerative colitis and withdrawal strategies
Fernando Bermejo, Javier P Gisbert
Clinical and Translational Gastroenterology
|
March 29, 2013
Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive Review
Javier P Gisbert, Xavier Calvet
Page
of 67
Search research articles
Search
Showing results (31-40 of 666) with videos related to
Sort By:
Page
of 67
Journal of Crohn'S & Colitis
|
November 29, 2019
Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice
Javier P Gisbert, María Chaparro
Gastroenterologia Y Hepatologia
|
December 5, 2020
How to prepare a research proposal in the health sciences?
Javier P Gisbert, María Chaparro
Journal of Crohn'S & Colitis
|
October 12, 2018
Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review
Javier P Gisbert, María Chaparro
Current Pharmaceutical Biotechnology
|
February 24, 2011
Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease
María Chaparro, Javier P Gisbert
Lancet (London, England)
|
October 23, 2016
Towards effective empirical treatment for Helicobacter pylori eradication
Francis Megraud, Javier P Gisbert
Gastroenterologia Y Hepatologia
|
October 19, 2017
Ustekinumab to treat Crohn's disease
Javier P Gisbert, María Chaparro
World Journal of Gastroenterology
|
September 24, 2008
Severe ulcerative colitis: at what point should we define resistance to steroids?
Maria Esteve, Javier P Gisbert
The American Journal of Gastroenterology
|
April 5, 2013
Response to Tung et al
María Chaparro, Javier P Gisbert
Therapeutic Advances in Chronic Disease
|
December 20, 2012
Usefulness of salicylate and thiopurine coprescription in steroid-dependent ulcerative colitis and withdrawal strategies
Fernando Bermejo, Javier P Gisbert
Clinical and Translational Gastroenterology
|
March 29, 2013
Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive Review
Javier P Gisbert, Xavier Calvet
Page
of 67